BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8189546)

  • 21. Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1.
    Brehm MA; Bonneau RH; Knipe DM; Tevethia SS
    J Virol; 1997 May; 71(5):3534-44. PubMed ID: 9094625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0.
    Martin S; Zhu XX; Silverstein SJ; Courtney RJ; Yao F; Jenkins FJ; Rouse BT
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2391-9. PubMed ID: 2172452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
    Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
    Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection.
    Jones CM; Cose SC; Coles RM; Winterhalter AC; Brooks AG; Heath WR; Carbone FR
    J Virol; 2000 Mar; 74(5):2414-9. PubMed ID: 10666272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.
    Salvucci LA; Bonneau RH; Tevethia SS
    J Virol; 1995 Feb; 69(2):1122-31. PubMed ID: 7529328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute morphine administration reduces cell-mediated immunity and induces reactivation of latent herpes simplex virus type 1 in BALB/c mice.
    Mojadadi S; Jamali A; Khansarinejad B; Soleimanjahi H; Bamdad T
    Cell Mol Immunol; 2009 Apr; 6(2):111-6. PubMed ID: 19403060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.
    Koelle DM; Chen HB; Gavin MA; Wald A; Kwok WW; Corey L
    J Immunol; 2001 Mar; 166(6):4049-58. PubMed ID: 11238653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.
    Yasukawa M; Zarling JM
    J Immunol; 1985 Apr; 134(4):2679-82. PubMed ID: 2579149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.
    Coles RM; Mueller SN; Heath WR; Carbone FR; Brooks AG
    J Immunol; 2002 Jan; 168(2):834-8. PubMed ID: 11777979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
    Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
    J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice.
    Jennings SR; Bonneau RH; Smith PM; Wolcott RM; Chervenak R
    Cell Immunol; 1991 Mar; 133(1):234-52. PubMed ID: 1671342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes.
    Jennings SR
    J Immunol; 1985 Nov; 135(5):3530-6. PubMed ID: 2413124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase.
    Sloan DD; Zahariadis G; Posavad CM; Pate NT; Kussick SJ; Jerome KR
    J Immunol; 2003 Dec; 171(12):6733-41. PubMed ID: 14662877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
    Posavad CM; Wald A; Hosken N; Huang ML; Koelle DM; Ashley RL; Corey L
    J Immunol; 2003 Apr; 170(8):4380-8. PubMed ID: 12682275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress-induced suppression of herpes simplex virus (HSV)-specific cytotoxic T lymphocyte and natural killer cell activity and enhancement of acute pathogenesis following local HSV infection.
    Bonneau RH; Sheridan JF; Feng NG; Glaser R
    Brain Behav Immun; 1991 Jun; 5(2):170-92. PubMed ID: 1654165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity.
    Ali SA; Lynam J; McLean CS; Entwisle C; Loudon P; Rojas JM; McArdle SE; Li G; Mian S; Rees RC
    J Immunol; 2002 Apr; 168(7):3512-9. PubMed ID: 11907113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of cytotoxic T lymphocyte activity after inoculation of herpes simplex virus into the anterior chamber of mice.
    Watanabe M; Sakata H; Tsumura K
    Ophthalmologica; 1994; 208(6):325-8. PubMed ID: 7845649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47.
    Jugovic P; Hill AM; Tomazin R; Ploegh H; Johnson DC
    J Virol; 1998 Jun; 72(6):5076-84. PubMed ID: 9573278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.